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Objectives 19 
Large studies focusing on restrictive cardiomyopathy in the cat are scant. The aims of this retrospective 20 
study were to describe epidemiological characteristics and to analyze prognostic factors affecting 21 
survival in cats with restrictive cardiomyopathy. 22 
 Methods 23 
The clinical archives of the Clinica Veterinaria Gran Sasso (Italy) and of the cardiology unit of the 24 
Department of Veterinary Medicine (University of Milan, Italy) from 1997 to 2015 were reviewed for all 25 
cats diagnosed with restrictive cardiomyopathy based on an echocardiographic exam (left atrial/biatrial 26 
enlargement, normal left ventricle wall thickness, normal or mildly decreased systolic function and 27 
restrictive left ventricle filling pattern with pulsed Doppler echocardiography)  28 
Results 29 
The study population comprised 90 cats (53 male and 37 female) with an echocardiographic diagnosis of 30 
restrictive cardiomyopathy. Most were domestic shorthair (n=60) with a mean age of 10.0±4.3 years and 31 
a median weight of 3.8 kg (IQR 3.2-5 kg). Most cats were symptomatic (n=87). The most common clinical 32 
sign was respiratory distress (n= 75). Follow-up was available on 60 cats and the median survival time 33 
(MST) was 69 days (95% CI 0-175 days). Cardiac-related death occurred in 50 cats. In the multivariate 34 
Cox analysis only respiratory distress showed a statistically significant effect on survival. The cats 35 
without respiratory distress showed a MST of 466 days (95%CI 0-1208); cats with respiratory distress 36 
showing a MST of 64 days (95%CI 8-120, p=0.011).  37 
Conclusions and relevance 38 
RCM can be considered an end stage condition associated with a poor prognosis, with few cats not 39 
showing clinical signs and surviving longer than a year: most cats died for cardiac disease in a very short 40 
time.   41 
Introduction 42 
Restrictive cardiomyopathy (RCM) is a myocardial disorder characterized by myocardial stiffness, severe 43 
diastolic dysfunction (restrictive physiology) and an overall poor prognosis.1-4 It is not clear if some of 44 
the RCM cases may be considered the end result of other forms of cardiomyopathy (CM), mainly 45 
hypertrophic cardiomyopathy (HCM) and myocarditis.2,5-10 As serial echocardiographic exams are seldom 46 
available for review to substantiate changes in the echocardiographic appearance, it is difficult to 47 
quantify or identify if different separate etiologies contribute to a common end-stage pattern. RCM is 48 
often morphologically sub-classified into two forms: myocardial and endomyocardial.1 Echocardiography 49 
allows classification and is at the moment the most common tool for diagnosis. Both forms of RCM are 50 
characterized by atrial enlargement, normal left ventricular (LV) wall thickness, normal or mildly 51 
decreased systolic function. and restrictive LV filling pattern with pulsed Doppler echocardiography; in 52 
the endomyocardial form, thick hyperechoic tissues bridge the LV lumen.1-4,8 Large studies focusing on 53 
RCM in the cat are scant.2,3 The aims of this retrospective study were to describe epidemiological 54 
characteristics and to analyze prognostic factors affecting survival in cats with RCM. 55 
Materials and methods 56 
The clinical archives of the Clinica Veterinaria Gran Sasso (Italy) and of the cardiology unit of the 57 
Department of Veterinary Medicine (University of Milan, Italy) were reviewed to identify cats diagnosed 58 
with RCM based on an echocardiographic exam from 1997 to 2015. Inclusion criteria were any patient 59 
with a complete case record (owner data, patient signalment and anamnesis, complete clinical findings 60 
and cardiac investigation) and an echocardiographic diagnosis of RCM.  61 
The diagnosis was based in both institutions on the echocardiographic presence of: left atrial/biatrial 62 
enlargement, normal LV wall thickness (m-mode LV wall thickness in diastole < 6mm measured by the 63 
leading edge to leading edge method), normal or mildly decreased systolic function and restrictive LV 64 
filling pattern with pulsed wave Doppler echocardiography (E wave/A wave ratio [E/A] >2).2,4,8 The latter 65 
criteria was not strictly considered for inclusion in cases where E and A waves were summated (for 66 
tachycardia) or A wave was absent (due to supraventricular arrhythmia) and all previously mentioned 67 
echocardiographic characteristics were present. In case of focal hypertrophy (> 6 mm in M-mode or B 68 
mode measurements) the case was excluded from the study.  69 
Left atrial enlargement was defined by a left atrium to aortic root ratio (LA/Ao) greater than 1.5 on B-70 
mode.11 Left atrial enlargement was subsequently classified as mild to moderate if the LA/Ao ratio was 71 
1.5-2.0, while cats with a LA/Ao ratio >2.0 were considered to have severe LA enlargement.11 72 
Echocardiographic signs of increased risk for arterial thromboembolism (ATE) included the presence of 73 
spontaneous echocardiographic contrast (‘smoke effect’) or the direct visualization of intracardiac 74 
thrombi in the left atrium or auricle.  75 
 Cats diagnosed with a CM other than RCM, congenital heart disease, systemic hypertension, 76 
hyperthyroidism or those with incomplete case records were excluded from the analysis. 77 
Systemic systolic blood pressure was assessed non-invasively using a Doppler-based technique in all 78 
patients as recommended by the American College of Veterinary Internal Medicine Guidelines.12 When 79 
BP was >150 mmHg on serial repeated measurements, the cat was classified as affected by systemic 80 
hypertension and excluded from the study.13 All cats older than 10 years of age had their T4 levels 81 
tested.14 If the patient presented with a clinical history or with clinical findings related to the presence of 82 
hyperthyroidism (polyphagia, progressive weight loss), T4 levels, haematology and biochemistry were 83 
performed regardless of the patient’s age. Thoracic radiograph were performed in all cats with 84 
respiratory distress.  85 
Respiratory distress was defined by the presence of increased respiratory rate associated with an 86 
increase in effort and/or open mouth breathing and/ or orthopnea. Increased respiratory rate 87 
(tachypnoea) alone was not considered sufficient due to the possibility of tachypnoea being identified in 88 
normal cats in the hospital environment.15  89 
Follow-up status and cause of death was determined by reviewing the medical records and/or phone 90 
interviews with the owners by investigators or trained senior veterinary students, when more 91 
information was required. If the cats had died, an attempt was made to classify the events as cardiac 92 
related or not. Cardiac-related death was defined as death occurring because of progression of clinical 93 
signs of heart failure (HF)/ATE. Euthanasia because of refractory HF/ATE was scored as cardiac-related 94 
death. Sudden death was regarded as cardiac-related if no other cause of death was obvious. Cats still 95 
alive or that had died or were euthanized for reason unrelated to cardiac disease were censored in the 96 
statistical analysis. Subjects lost to follow-up were included in the survival analysis up until the last time 97 
point at which they were known to be alive and then were thereafter censored in the analysis. 98 
 99 
Statistical analysis 100 
Basic descriptive statistical analyses were performed using Microsoft Excel. Data were analyzed using a 101 
commercially available software (SPSS Statistics for Windows v23). In all cases a P value <0.05 was 102 
described as significant. The Shapiro-Wilk test was used to verify variables normal’s distribution. 103 
Normally distributed data were reporter as mean ± SD and non-normally distributed data as median and 104 
interquartile range (IQR).  105 
Survival time was calculated from the time of diagnosis to the date of death or last telephone contact. 106 
The Kaplan-Meier method was used to estimate the survival function and plot time to event curves in 107 
the different group. A log-rank test with right-censoring was used to determine whether a significant 108 
difference existed between groups. 109 
Schoenfeld residuals and time dependent covariates were used to test the assumption of proportional 110 
hazards. Univariate and multivariate Cox proportional hazard analysis were performed in order to 111 
determine the effect of any variable on survival. Hazard ratio (HR) and 95% confidence intervals (CI) 112 
were calculated. 113 
Variables were added to the multivariable model in a manual stepwise manner, including first all 114 
variables statistically significant in the univariate analysis, and then excluding those not reaching 115 
statistical significance one by one, until all the variables included were statistically significant (backwards 116 
regression analysis). 117 
Variables assessed for their effect on outcome were breed (longhair vs shorthair), sex, age at 118 
presentation, presence of clinical signs (respiratory distress, syncopal episode, limbs paresis/paralysis) 119 
presence of pleural/pericardial effusion, pulmonary edema and abdominal distension,and 120 
echocardiographic variables (left atrium/aortic ratio, mild-moderate or severe left atrial enlargement, LV 121 
FS, LV dimensions in systole/diastole and presence of echocardiographic signs of increased risk for ATE)..  122 
Results 123 
From January 1997 to December 2015, 767 cats were diagnosed with a CM; most cats had HCM (594 124 
cats, 77.5%), 115 cats (15%) were classified as RCM, 34 cats (4%) as dilated CM (DCM), 22 cats (3%) as 125 
unclassified CM (UCM) and 4 cats (0.5%) as arrhythmogenic right ventricular cardiomyopathy. Twenty-126 
five cats with RCM were thereafter excluded because they didn’t meet the inclusion criteria (12 127 
incomplete case records and 13 incomplete echocardiographic reports). The final study population 128 
comprised 90 cats with an echocardiographic diagnosis of RCM. 129 
Male cats were predominant in the population (58.9% were male and 41.1% were female). Forty-three 130 
male and 34 female were neutered. Breed population included mostly domestic shorthair cats (n=60, 131 
67%), followed by Persians (n=15, 17%), longhair cats (n=11, 12%; four Norwegian Forest Cats, four 132 
Birman and three Maine Coons), three Siamese cats and one Chartreux. At presentation the mean age 133 
was 10.0 ± 4.3 years and the median weight was 3.8 kg (IQR 3.2-5 kg). The majority (n=87; 97%) of cats 134 
had clinical signs at presentation, with only three cats asymptomatic. Only the minority of cats had a 135 
murmur (n=9; 10%). Twelve cats (13%) presented supraventricular arrhythmias. 136 
Presenting complaints are listed in table 1.  137 
Thoracic radiographs were performed in the 75 cats (83%) presenting with respiratory distress. Pleural 138 
effusion was observed in 44 cases (58.7%), pulmonary edema in 19 (25.3%) and both in 12 cases (16%).  139 
All cats received a therapy with furosemide and ACE inhibitors. Diltiazem was administered in all cats 140 
that presented with supraventricular arrhythmias. Anti-thrombotic treatment (aspirin low dose before 141 
January 2013 or clopidogrel after) was administered in all cats with clinical and/or echocardiographic 142 
signs of increased risk of ATE (presence of thrombus, smooke effect) and/or moderate atrial dilatation, 143 
(LA/Ao>1.8 ). 144 
All cats included in the study were conscious, unsedated, manually restrained during the 145 
echocardiographic examination. Echocardiographic parameters in cats with RCM are showed in Table 2. 146 
All cases had a restrictive pattern with the exception of 18 cats: 6 cats had the E wave summated to the 147 
A wave for tachycardia and 12 cats had supraventricular arrhythmia and the A wave absent. Most cats 148 
had severe left atrial enlargement (n=72, 80%) and 25 cats (27.8%) presented echocardiographic signs 149 
for increased risk of ATE (smoke effect or mural thrombi). Patchy or extensive areas of increased 150 
echogenicity of the endocardium were observed in only 2 cases. During the echocardiographic 151 
examination pericardial effusion was observed in 6 cats. 152 
Follow-up was available on 60 cats and the median survival time (MST) was 69 days (95% CI 0-175 days). 153 
Cardiac-related death occurred in 50 cats (83%), 5 cats were still alive at last follow-up and 5 cats had 154 
died from unrelated cardiac causes (3 neoplasia and 2 chronic kidney disease). 155 
In the univariate Cox analysis respiratory distress, pleural effusion and left atrial enlargement (mild-156 
moderate versus severe) showed a statistically significant effect on survival with a HR (95% CI) 157 
respectively of 3.54 (1.25-9.99; p=0.017), 2.34 (1.16-4.71; p=0.017) and 2.32 (1.08-4.99; p=0.031). In the 158 
multivariate Cox regression backward analysis only respiratory distress showed a statistically significant 159 
effect on survival. Cats presenting without respiratory distress showed a MST of 466 days (95%CI 0-160 
1208), in contrast with cats that presented with respiratory distress showing a shorter (p=0.011) MST of 161 
64 days (95%CI 8-120) (Figure 1).  162 
Discussion 163 
The present results showed that RCM is almost exclusively diagnosed at late stage when the patients are 164 
referred after the development of clinical signs. Additionally, long term prognosis is poor. Almost all cats 165 
in our study showed signs of congestive HF alongside with cardiogenic thromboembolism and this is 166 
similar to what has previously been reported in literature.2,3,16 167 
Prognosis is poor as shown by the short survival time after the diagnosis: the MST in our study 168 
population is slightly shorter (2 months) than the MST reported by Fox (3 months) and Ferasin (4 169 
months) and longer that the MST reported by Kimura (1 month).2,3,16 Survival seemed better in those 170 
cats not presenting with respiratory distress, however they were only a minority.   171 
In our study respiratory distress is the only factor affecting the survival in the multivariate analysis 172 
(stronger than pleural effusion and atrial enlargement): this fact emphasizes how in a population of cat 173 
with RCM the presence of respiratory distress is the most useful variable in order to distinguish cats with 174 
poor prognosis.  175 
In our study population, RCM was the second most commonly diagnosed CM in cats with a 10-year 176 
prevalence of 15 % in all cats with CM referred to our two centres. DCM and UCM were otherwise less 177 
common, with a prevalence of 4% and 3%. In our institutions diagnosis of DCM was based on the 178 
echocardiographic observation of LV end systolic diameter >14 mm and a fractional shortening (FS) 179 
<28% in M-mode and diagnosis of UCM was made by exclusion, on the basis of evidence of myocardial 180 
abnormality that did not fit to any of the recognized disease classification.3 A variable prevalence in RCM 181 
has been reported in cats, with Schober reporting the lowest prevalence of RCM, at 2.4% of all cases of 182 
primary feline CM (n = 450) diagnosed between 2007 and 2015 (91.5% were HCM, 2.4% DCM, 2.7% 183 
UCM, and 1.1% were ARVC); also in a study performed by Fox (2014), the prevalence of cats with RCM 184 
was low (5%).2,17 In another report from Japan the RCM prevalence (endomyocardial form) was slightly 185 
higher with a prevalence of 13% (327 autopsies from cats with heart disease in 10-year).
16
 In contrast in 186 
a retrospective study from the UK including 105 cats with primary CM the prevalence of RCM was 21%.3 187 
These differences on RCM prevalence probably are related to different diagnostic criteria used. Both 188 
inter- and intraobserver agreement for myocardial disease classification in cats has also been reported 189 
to be poor.18 Most authors would agree that there is marked overlap between CM categories and there 190 
is a possibility, yet infrequently observed, of a change in CM (eg: an end stage HCM with LV wall thinning 191 
may result phenotypically more a RCM/DCM than HCM); there are examples of families of cats 192 
(Norwegian forest) that include individuals with HCM and RCM, or a mixed HCM/RCM phenotype.8,9 193 
Moreover restrictive ventricular physiology is not RCM-specific but rather occurs over a wide range of 194 
myocardial pathologies, end-stage in particular. In general, definitive qualitative and quantitative 195 
echocardiographic criteria and diagnostic cutoffs in the diagnosis of feline RCM are poorly defined and 196 
remain controversial with only 1 study reporting objective data.2,17 Challenge is the diagnosis not only by 197 
echocardiography, but also by pathology because accepted objective histopathology criteria in the 198 
diagnosis of feline RCM are lacking.17 Therefore, the prevalence may have been influenced by the 199 
different diagnostic criteria and classification in different studies. Geographical distribution may also be 200 
another source of prevalence variation between the studies.  201 
None of the cats in this study showed transition into a different CM. 202 
Several previous RCM studies have shown a female predisposition or equal predisposition. 2,3,19 Similar 203 
to Kimura in our study cats with RCM were predominantly male.16 The most represented breed was 204 
domestic shorthair cat, that is the most common cat breed in Italy.19 205 
The mean age at presentation reflects the adult-onset of the disease as reported by literature.2,3,16 The 206 
wide range of the age at diagnosis may reflect a wide disease onset, as is the case for HCM, or it could 207 
indicate the presence of different underlying pathogenesis leading to a common final echocardiographic 208 
appearance,, as could be the case for acute myocardial damage, myocarditis, end stage HCM or 209 
neoplasia.8 210 
A heart murmur was rarely identified in cats with RCM in our study, which is similar to what has been 211 
previously reported; the lack of a heart murmur is in line with the current observations that the 212 
presence or absence of a heart murmur is not a useful screening tool in cats.20  213 
Endomyocardial fibrosis was identified only in 2 cats. It is possible that this type of RCM might have 214 
been underdiagnosed during echocardiographic examination due to their location and size, the quality 215 
of the ultrasonographic equipment, the skill of the operator and the lack of cooperation of some 216 
patients. 217 
Limitations of this study were mainly related to its retrospective nature. Diagnosis was based only on 218 
echocardiography and post-mortem was available only in few cases; no cardiac biomarkers were 219 
available. B-mode measurements of LV wall thickness was not available in all cases, but those were a 220 
minority. The authors chose a value of ≥ 6 mm for the definition of LV hypertrophy based on previously 221 
published studies and no allometric scaling was used in order to control the effect of the body 222 
weitgh.2,4,21 No other diastolic information were available in cats with summated E and A waves for 223 
tachycardia or A wave absent for arrhythmia. The distribution of CMs might be biased by the 224 
echocardiographic criteria used in both referral centers where the study was carried, however no 225 
consensus in cardiomyopathy classification is currently available in veterinary cardiology for uniform 226 
classification of feline cardiomyopathies.18 No cat included in the study was previously diagnosed with 227 
HCM based on a previous echo; the authors excluded cases in which focal hypertrophy was present in 228 
an attempt to exclude end stage HCM, nevertheless the authors cannot completely rule out that some 229 
cats with HCM could have been included. Treatment in the current population was not standardized but 230 
consisted mainly of loop diuretics, ace inhibitors and anti-thrombotic treatment. Finally, owner related 231 
information could have biased the results due to misinterpretation of clinical signs or failure to 232 
recognize cardiac-related death. 233 
Conclusion  234 
RCM can be considered an end stage condition associated with a poor prognosis, with few cats not 235 
showing clinical signs and surviving longer than a year: most cats died for cardiac disease in a very short 236 
time.  237 
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